Company ProfilePremium

Mufin Green Finance Limited (formerly APM Finvest Limited)

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Mufin Green Finance Limited - Company showcase

Year Founded & Workforce

2016

537 Employees

Mufin Green Finance Limited logo

Mufin Green Finance Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Mufin Green Finance Limited Overview

FieldDetail
Current legal nameMufin Green Finance Limited ("MGFL")
Former nameAPM Finvest Limited (May 2016 – mid-2022)
Date of name change15 July 2022 per most CMOTS-derived profiles; one CMOTS table records 11 June 2022 (discrepancy noted) [Src: Arihant Capital/CMOTS company profile and name-change table]
Incorporation13 May 2016, State of Rajasthan, as a public limited company [Src: CMOTS profile; BSE filings]
Original CINL65990RJ2016PLC054921 (Rajasthan) [Src: BSE filings 2020–2022]
Current CINL65990DL2016PLC447681. The "DL" code indicates the registered office has moved to Delhi [Src: Tracxn legal-entity record, 2026]
Original registered officeSP-147, RIICO Industrial Area, Bhiwadi, District Alwar, Rajasthan 301019
Current HQ / corporate office201–202, 2nd Floor, Best Sky Tower, Netaji Subhash Place, Pitampura, New Delhi 110034 [Src: BSE filing May 2022; Morningstar; BRSR FY2024]
Regulatory statusRBI-registered Non-Banking Financial Company, Non-Deposit Taking (NBFC-ND). Registered with RBI's Jaipur Regional Office on 16 Feb 2017 [Src: company "About" text via InvestYadnya]
Listing – BSEScrip code 542774 (symbol now MUFIN). Listed September 2019 after the demerger [Src: Simply Wall St listing record; BSE]
Listing – NSESymbol MUFIN, listed 6 November 2023 (initially in the BE series) [Src: NSE letter NSE/LIST/136 dated 2 Nov 2023; NSE circular 3 Nov 2023]
ISININE08KJ01020 (current). The earlier ISIN INE08KJ01012 applied before the face-value change [Src: CMOTS; BSE Form C filing Dec 2020]
CUSIPNot applicable (no US listing)
Face value₹1 per share (current); ₹2 at the original 2019 allotment
Shares outstanding~19.82 Cr after the March 2026 preferential allotment, before later warrant and ESOP conversions [Src: allotment filing 4 Mar 2026]
Fiscal year end31 March
Statutory auditorM/s Gaur & Associates, Chartered Accountants. Appointed 28 Aug 2025 to fill the casual vacancy left by the resignation of M/s Tattvam & Co.; term FY2025–28, subject to AGM approval [Src: Board outcome 28 Aug 2025]
Secretarial auditorM/s Abhay K & Associates (FY2025–30) [Src: same]
Parent / promoterHindon Mercantile Limited (Mufin Group) together with Kapil Garg and family [Src: Acuité rationales; CMOTS]
Employees481 (BRSR FY2024); ~537 (third-party, FY2025); management targets ~300 (FY2026 call commentary) — see trend table below
Market capitalisation~₹2,797 Cr at ₹141/share (19 Oct 2026, NSE/BSE close) [Src: Screener.in, 19 Oct 2026]
Websitewww.mufingreenfinance.com (legacy www.apmfinvest.com still referenced on aggregators)

The entity in the source list, APM Finvest Limited (BSE: 542774, "APMFINVEST.BO"), still exists as the same legal entity but has been renamed Mufin Green Finance Limited. Control passed from the Rajgarhia family (APM Industries group) to Hindon Mercantile Limited and Mr. Kapil Garg in March 2022. The renaming followed in mid-2022.

MetricFY2024FY2025FY2026
Total employees (number)481537—

Notes: FY2024 is from the company's BRSR (421 male, 60 female) [Src: BRSR FY2023-24]. The FY2025 figure is a third-party estimate [Src: Musaffa, Dec 2025]. A FY2026 closing headcount is not publicly disclosed in the sources reviewed. Company materials cite a 15.83% workforce reduction across the four quarters of FY2026 [Src: Q4 FY26 investor presentation], and a 26.45% headcount reduction against 6.9x disbursement growth over a longer period, with a stated goal of ~300 employees [Src: Tickertape summary of FY26 call]. Blank = not publicly disclosed.

Mufin Green Finance is a New Delhi-based, RBI-registered NBFC-ND listed on NSE and BSE. It occupies the shell of the former APM Finvest, the investment-company demerger vehicle of APM Industries. After Kapil Garg's Mufin Group took control in March 2022, the company was repositioned as what it calls India's first listed NBFC dedicated to electric-vehicle (EV) and climate finance. It lent against e-rickshaws, electric two- and three-wheelers, chargers, swappable batteries and later solar assets. Since FY2026 the strategy has pivoted sharply toward fully digital, low-touch retail credit: mediclaim (health-insurance) premium financing through 10+ insurer integrations, and "Salary Saathi" payroll-linked loans to government employees. Climate lending and secured MSME loans remain important but are declining as a share of the book. AUM reached ₹1,599 Cr in June 2026, up 69% YoY. Management guides to ₹2,500 Cr AUM and ₹80–90 Cr PAT for FY2027. The equity trades at a steep premium to book (~4.9x), so the investment case depends on whether the mediclaim pivot delivers both scale and quality.


What the company does

Vertical (as reported)AUM INR Cr (30 Jun 2026)Share of AUMCharacter
Mediclaim Financing676.6142%Converts lump-sum health-insurance premiums into EMIs at point of sale via insurer integrations; fully digital, no branches
Other Loans (MSME & corporate)458.8429%Collateral-backed loans to MSMEs and corporates; management says 100% collateral-backed
Climate Financing (EV & Solar)410.8326%Loans and leases for EVs (2W/3W/4W), chargers, swappable batteries and solar; company cites IoT-backed asset monitoring
Salary Saathi52.973%Payroll-linked personal loans to government and PSU employees; management claims near-zero default risk because repayment comes via payroll
Total AUM1,599.23100%—

MGFL is a balance-sheet lender. It borrows from banks, NBFCs, development finance institutions (DFIs), NCD investors and offshore bond investors. It then on-lends to retail and small-business borrowers, earning a net interest spread plus processing and other fees. As of Q1 FY2027 (June 2026) the loan book had four reported verticals [Src: Q1 FY27 investor update; ScanX/Multibagg summaries, Aug 2026]:

Note: the sum of the four verticals (1,599.25) matches reported total AUM (1,599.23) within rounding (computed).

Business and revenue model

Revenue model: About 99% interest income on loans and leases. Revenue from operations was ₹210.29 Cr in FY2026 [Src: FY26 results via ScanX]. Q1 FY2027 interest income was ₹76.44 Cr of ₹76.86 Cr revenue [Src: Chola Securities news feed; Whalesbook]. Fee, processing and lease-rental income are small and not separately broken out in the sources reviewed. There is no product, subscription or licensing revenue.

Funding model: Wholesale funded. Total borrowings were ₹1,550.99 Cr at a cost of 11.17% in Q1 FY2027 [Src: Q1 FY27 funding slide via Multibagg]. Sources include term loans from public and private banks (SBI, ICICI Bank, Union Bank of India and others), IREDA, AU Small Finance Bank, Kotak Mahindra Investments, NCDs (domestic, including the Wint Wealth platform), USD-denominated bonds and notes listed on India INX/Global Securities Market, a US DFC 10-year loan, BlueOrchard debt, and securitisation via PTC trusts rated by CRISIL ("MediClaim Trust 2026", "Astral Trust 2026").

Value chain position: Last-mile credit originator. In mediclaim, MGFL sits between insurer and policyholder at the point of sale, embedded in insurer or distributor journeys. In EV, it originates through OEMs, dealers and fleet operators using a "phygital" model of digital underwriting plus in-house field sales and collections. In Salary Saathi, it relies on employer or government payroll arrangements; an Assam government empanelment was announced and then clarified in March 2026.

Customer types: (i) retail insurance policyholders; (ii) drivers and owners of e-rickshaws and electric 2W/3W, often in rural and semi-urban areas; (iii) EV fleet operators, OEMs, dealers and charging/battery-swap operators; (iv) MSMEs and corporates; (v) salaried government and PSU employees.

End-markets: Indian retail health-insurance distribution; Indian EV and clean-energy ecosystem; MSME credit; payroll-linked consumer credit.

The company's own description (paraphrased from FY2026 Annual Report and May 2026 investor presentation)

The company describes itself as India's first listed EV and mediclaim-financing NBFC. Its stated aims are to advance green mobility, renewable energy, financial protection and inclusive credit access. It says it has evolved from a pure climate financier into an ecosystem-enabled lender combining technology, sector-focused underwriting and a widening product range: mediclaim premium financing, salary-linked loans to government employees, and EV/clean-energy loans [Src: FY2026 Annual Report cover letter, NSE 5 Sep 2026; Investor Presentation 25 May 2026].

Independent characterisation

Since FY2026, MGFL is best described as a digital consumer-and-MSME lender with a legacy climate-finance book, not a "green NBFC." Three structural facts support this:

  1. Mediclaim financing grew from essentially nil to 39% of AUM by March 2026 and 42% by June 2026. Management targets 50–60% in FY2027 [Src: Q4 FY26 call transcript, 4 Jun 2026].

  2. The climate book's share fell to ~26% of AUM by Q1 FY2027, although its absolute size remained roughly ₹400–460 Cr.

  3. Operating leverage is the core thesis. FY2026 Q4 opex was flat YoY at ~₹10.4 Cr while AUM rose 84% [Src: FY26 press release via Agro Spectrum].

The "Green" in the name is now partly legacy branding. Mediclaim premium financing is short-tenor and relies on insurer-linked collections; its credit history at MGFL spans less than two years.

Strategy

Stated strategy (themes from FY2026 Annual Report, May 2026 presentation and Q4/Q1 calls, paraphrased)

  1. Product-led, tech-first lending: Concentrate growth in digital, branchless products (mediclaim premium financing and Salary Saathi) that management says carry high spreads and minimal delinquency.

  2. Ecosystem-enabled finance: Embed credit in partner journeys: insurers (10+ integrated), government payroll systems, EV OEMs and dealers, solar installers.

  3. Operating leverage: Keep opex flat while scaling AUM; cut headcount toward ~300.

  4. Funding diversification and cost reduction: Widen the lender base (PSU banks, NCD platforms, securitisation, ECB and offshore bonds, DFIs) and plan green bond issuance, leveraging the A- rating.

  5. Responsible growth and asset quality: Lower GNPA (1.94% → 1.91%) and Stage 2 (12.6% → 5.9%); keep collection efficiency above 96.5%.

Strategic initiatives in the last 24 months (Oct 2024 – Oct 2026)

DateInitiativeDetailSource
Jan 2025DFC 10-year US$18M loanLong-tenor funding for EV and solar financeYourStory, Jan 2025
Mar 2025LKP Finance majority stake (group)Capital base and Western India presence; later turned toward payments/rewards (Gyftr)Energetica, Mar 2025
FY2026Launch and scale of Mediclaim Premium Financing0 → ₹608 Cr AUM by Mar 2026Q4 FY26 call
FY2026Launch of Salary Saathi₹31 Cr (computed) → ₹53 Cr AUM by Jun 2026Presentations
Mar 2026Assam government empanelment (Salary Saathi)Press release 1 Mar 2026; clarification 3 Mar 2026IndiaIPO / ScanX
Mar 2026₹324 Cr preferential equity and warrantsGrowth capital; CRAR to 32%Allotment filing
FY2026Workforce rationalisation−15.83% headcount over four quartersQ4 FY26 presentation
FY2026–27Securitisation programmeCRISIL-rated PTCs: MediClaim Trust 2026 (Mar/May 2026), Astral Trust 2026 (Jul/Sep 2026)Screener credit-rating links
Jul 2026ECB / foreign-currency bonds up to US$6MBoard approval 14 Jul 2026; notes listed on India INX 22 Sep 2026Sahi; ScanX
FY2026–27Green bond planReferenced in FY26 funding commentary; size n/dMultibagg summary of FY26 presentation
Oct 2026ESOP allotmentsShares allotted on exercise, 13 Oct 2026BSE announcement

Management guidance and medium-term targets

Guidance itemFY2027 targetSource
AUM (INR Cr)2,500FY26 call / ScanX
PAT (INR Cr)80 to 90FY26 call / ScanX
Mediclaim share of AUM (%)50 to 60Q4 FY26 call transcript
Headcount (number)~300Tickertape summary

ESG or sustainability targets with dates are not publicly disclosed. No formal cost programme target exists beyond the headcount goal.

Analyst arithmetic on guidance: Q1 FY2027 PAT of ₹14.0 Cr annualises to ~₹56 Cr. Reaching ₹80–90 Cr implies an average of ~₹22–25 Cr per quarter over Q2–Q4, i.e., a 60–80% step-up from the Q1 run rate. AUM must grow ~56% over FY2027 (₹1,599 Cr → ₹2,500 Cr in nine months, ~₹100 Cr per month).

Products & Services

Flagship offerings: Mediclaim Financing (largest and highest-growth); Climate Financing (legacy franchise and brand identity); Salary Saathi (emerging, high-quality payroll credit). Ticket sizes, tenors, interest-rate bands and fees by product are not publicly disclosed in the sources reviewed.

Product Portfolio

#Product / offeringVerticalDescription & key features (as disclosed)Target customerLaunch / latestPricing
1

Mediclaim Premium Financing (insurance-premium EMI)

Mediclaim

Converts annual health-insurance premiums into monthly EMIs at the point of sale. Paperless and instant; integrated with 10+ insurers. Management says no branches or manpower are needed and NPA is "almost negligible"

Retail health-insurance buyers

Scaled during FY2026; 39% of AUM by Mar-26

n/d; management cites a spread above 7–8%

2

Salary Saathi

Salary Saathi

Payroll-linked personal loans for government and PSU employees, repaid through salary deduction. Assam government empanelment announced 1 Mar 2026 and clarified 3 Mar 2026

Government/PSU employees

FY2026

—
3

E-rickshaw / e-3W loans

Climate

The original Mufin product since 2016: income-generating vehicle loans for drivers, largely rural and semi-urban

Individual drivers, owner-operators

2016 (group); in MGFL since 2022

—
4

Electric 2W loans

Climate

Retail EV loans through OEM and dealer tie-ups

Individuals, delivery riders

2022–23

—
5

Electric 4W / LCV / bus financing

Climate

Announced extension into buses, LCVs and commercial 4W (Feb 2024)

Fleet operators

2,024—
6

Swappable / non-swappable battery financing and leasing

Climate

Loans and leases for battery packs; supports battery-as-a-service

Fleet and swap operators

2,022—
7

EV charger / charging-infrastructure finance

Climate

Loans for chargers and charging stations

CPOs, dealers, businesses

2,022—
8

Top-up loans for existing EV customers

Climate

Additional credit lines on performing loans

Existing borrowers

2,022—
9

Solar asset financing (commercial and industrial)

Climate

Rooftop and asset finance for hotels, hospitals, offices and factories

C&I customers

2024–25

—
10

Solar ecosystem finance

Climate

Working capital for solar projects; individual, group and captive PPA financing; supply-chain finance across OEMs, distributors and installers

Developers, installers, OEMs

2,025—
11

Dealer / OEM supply-chain and working-capital finance

Climate / MSME

Term loans, working capital, supply-chain finance and lease structures for the EV value chain

OEMs, dealers

2023–24

—
12

MSME & corporate secured loans ("Other Loans")

MSME

Collateral-backed term and working-capital loans; management says 100% collateral-backed

MSMEs, mid-corporates

FY2025

—
13

Leasing (via Mufin Green Leasing Pvt Ltd)

Climate

Operating/finance lease of EV assets

Fleets

2,023—
14

Green infrastructure (via Mufin Green Infra Ltd, 65%)

Climate

Purpose not detailed in reviewed sources

—2,024—

Financial Narrative

Basis: Standalone Ind AS figures as compiled by Screener.in/C-MOTS from audited annual results, rounded to ₹ Cr, cross-checked with company releases where available. FY2023–FY2026 reflect the post-acquisition lending business; FY2022 still reflects the legacy investment company. NBFC accounting means "gross profit", "EBITDA" and "capex" are not standard concepts; NBFC equivalents (net interest income, pre-provision operating profit) are used and labelled.

Income statement (₹ Cr, standalone)

Sources: Screener.in standalone P&L FY2022–FY2026. FY2023/FY2024 revenue and PAT from the company's FY2024 results (Goodreturns, May 2024). FY2026 revenue (₹210.29 Cr) and PAT (₹28.21 Cr, +39.1% YoY) from FY26 results (ScanX). FY2025 PAT of ₹20.28 Cr is computed from ₹28.21 Cr ÷ 1.391; Chola Securities reports ₹19.61 Cr for FY2025, likely the consolidated figure (discrepancy noted). Aggregator EPS is shown as reported and may not be fully restated for the 2:1 bonus and later issuances; diluted EPS is not publicly disclosed in the reviewed sources. Screener records a 4% dividend payout for FY2022 (legacy APM era); no dividends since.

Margins and growth (computed)

Revenue CAGR FY2022–FY2026 (4 years): ~94% (computed from ₹15 Cr to ₹210.29 Cr). Revenue CAGR FY2023–FY2026 (3 years): ~83% (computed; matches Screener's 83%).

The company's own cost-to-income ratio is 45.8% for FY2026 (47.5% in Q4 FY2025) [Src: Q4 FY26 presentation]. This differs from the computed proxy above because of different treatment of provisions and other income.

Balance sheet (₹ Cr, standalone, 31 March)

Sources: Screener.in standalone balance sheet. Loans for FY2023 (₹25,853.45 lakh) and FY2024 (₹61,929.57 lakh) from the audited Statement of Assets and Liabilities (NSE filing, 28 May 2024). AUM from investor presentations. The short-term / long-term debt split, cash and equivalents, and working capital are not publicly disclosed in the aggregator data reviewed. Working capital is not a meaningful NBFC metric. Goodwill/intangibles are shown as nil because none appear in aggregator data; this should be verified against the annual report.

Net debt: Cash balances are not disclosed in the sources reviewed, so net debt cannot be computed. Gross borrowings were ₹1,398 Cr at FY2026 (standalone balance sheet) and ₹1,550.99 Cr at 30 June 2026 (company funding slide).

Cash flow (₹ Cr, standalone)

Source: Screener.in. For a lender, negative operating cash flow mainly reflects loan-book growth (loans are operating assets), not operating losses. FCF is therefore not a meaningful metric. Capex is minimal (fixed assets ₹6–9 Cr).

Ratios (computed unless stated)

Sources: CRAR from ScanX (5 Sep 2026, FY2026). GNPA/NNPA from FY26 press release and ICICI Direct (NNPA 1.65% vs 2.12%; GNPA 1.94% vs 2.48–2.50%). Stage 2 from Q4 FY26 presentation. Company ROE/ROA from Q4 FY26 presentation. Current ratio, ROIC, net debt/EBITDA and cash conversion cycle are not meaningful for an NBFC and are omitted. Q1 FY2027: GNPA 1.91%; cost of borrowings 11.17%, down 263 bps YoY from 13.80% [Src: Q1 FY27 update; ScanX].

Quarterly trajectory (₹ Cr, standalone)

Sources: Screener quarterly (rounded); Q4 FY2026 revenue and PAT from MarketsMojo/ICICI Direct (consolidated ₹64.67 Cr / ₹11.09 Cr); Q1 FY2027 from Whalesbook/Multibagg; AUM and disbursements from the Q4 FY26 call transcript. Q1 FY2027 disbursements total is not stated in the reviewed sources; mediclaim alone was ₹247.08 Cr, and one summary cites ₹449 Cr of quarterly disbursements (+37.3%) but with an inconsistent AUM reference, so it is not used. Q1 FY2026 PAT is ₹3.14 Cr consolidated (company presentation); one source cites ₹4.1 Cr standalone (discrepancy).

Commentary on trends, inflections and drivers

Phase 1 — Investment shell (FY2017–FY2022). Under APM ownership the company held a listed-equity investment portfolio of ₹59–73 Cr with no borrowings. Earnings tracked mark-to-market swings: a ₹6 Cr loss in FY2020 and a ₹20 Cr profit in FY2021. In FY2022, investments fell from ₹73 Cr to ₹10 Cr and "other assets" (loans) rose to ₹91 Cr. This was the liquidation of the legacy portfolio around the change of control and its redeployment into lending.

Phase 2 — Leveraged EV-lending build-out (FY2023–FY2025). Borrowings rose from nil to ₹704 Cr and leverage from 0x to ~2.6x. NII rose from ₹28 Cr to ₹71 Cr, but the NII/revenue ratio collapsed from 81% to 44%. Funding costs were high at 13–14%, reflecting a BBB-rated issuer funded by NCDs, DFIs and small banks. ROA compressed from ~3.3% to ~2.1%. Asset quality in EV lending was mediocre: Stage 2 at 12.6% and GNPA ~2.5% at FY2025. PAT grew more slowly than revenue (FY2025 PAT +26% vs revenue +65%).

Phase 3 — Pivot and re-rating of funding (FY2026–Q1 FY2027). Three drivers changed together:

Product mix shift: to digital mediclaim and payroll loans.

Funding-cost decline: after Acuité's April 2025 upgrade to A-: cost of borrowings fell from 13.80% (Q1 FY2026) to 11.17% (Q1 FY2027), with Union Bank of India and Wint Wealth NCD lines added.

Operating leverage: Q4 opex flat YoY; Q1 FY2027 opex down 17.2% YoY to ₹13.55 Cr per company release.

The result was a sharp quarterly PAT inflection: ₹3.1 Cr in Q1 FY2026 to ₹14.0 Cr in Q1 FY2027. The ₹324 Cr preferential raise in March 2026 more than doubled net worth to ₹575 Cr, cutting leverage to ~2.4x and lifting CRAR to 32%. That will dilute ROE in FY2027 until the capital is deployed.

Data anomaly: One release reports Q1 FY2027 "pre-provisioning operating profit" of ₹62.98 Cr (+102% YoY) [Src: SolarQuarter, 13 Aug 2026]. This is arithmetically inconsistent with revenue of ₹76.86 Cr and finance cost of ~₹41 Cr, and likely mislabels gross interest income net of some item or NII. It should not be relied on.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRelationshipOwnershipIncorporatedFunction (as disclosed)

Hindon Mercantile Ltd

Parent / promoter

Holds controlling block with Kapil Garg family; promoter group total 47.30% (Jun 2026)

—

Mufin Group holding NBFC; original e-rickshaw financier

Mufin Green Finance Ltd

Listed entity

—

13 May 2016

NBFC-ND lender

Mufin Green Leasing Pvt Ltd

Subsidiary

100%

8 Aug 2023

Leasing (EV/battery assets; inferred from name)

Mufin Green Infra Ltd

Subsidiary

65%

2 Mar 2024

Green infrastructure (charging/solar; inferred)

LKP Finance Ltd (proposed rename "Gyftr")

Group company under common control

Majority acquired by "Mufin Group" in Mar–Apr 2025. Whether MGFL itself or the promoter group holds the stake is not clearly disclosed

—

Surrendering NBFC licence; holds 22% of Mufin Pay, which owns Gyftr (Vouchagram)

Mufin Pay

Group company

——

RBI-licensed PPI/wallet/UPI infrastructure

Bimapay Finsure Pvt Ltd

Kapil Garg directorship

———

Revenue by Segment

Vertical AUM (INR Cr)FY2025FY2026Q1FY2027

Mediclaim Financing

—607.88676.61

Climate Financing EV and Solar

—462.35410.83

Other Loans MSME and Corporate

—446.94458.84

Salary Saathi

—30.8252.97

Total AUM

838.441,541.171,599.23

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Vertical share of AUM (%)

Vertical share of AUM (%)FY2026Q1FY2027

Mediclaim Financing

3942

Climate Financing EV and Solar

3026

Other Loans MSME

2929

Salary Saathi

23

Revenue by Segment and Operating Metrics (number)

MetricQ1FY2026Q1FY2027YoY %

Mediclaim disbursements (INR Cr)

158.18247.0856.2

Mediclaim disbursement count (number)

32,50048,21448.4

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

1534.4397.70160.96210.29

Finance cost interest expense (INR Cr)

064590120

Net interest income proxy revenue minus finance cost (INR Cr)

1528537190

Operating expenses incl provisions (INR Cr)

216294250

Depreciation (INR Cr)

02233

Profit before tax (INR Cr)

1311212738

Tax rate (%)

1425242626

Net profit PAT (INR Cr)

118.1216.0620.2828.21

EPS basic as reported by aggregator (INR)

0.840.540.991.241.43

Dividend per share (INR)

00000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

NII as percent of revenue (%)

10081544443

Cost to income opex over NII (%)

1357555956

PBT margin (%)

8732211718

Net margin PAT over revenue (%)

7324161313

Revenue growth YoY (%)

-351301846531

PAT growth YoY (%)

-45-26982639

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

1033959261,0212,028

Loans net (INR Cr)

—258.53619.30——

AUM reported (INR Cr)

———838.441,541.17

Investments (INR Cr)

10355165

Fixed assets (INR Cr)

23967

Equity share capital (INR Cr)

45161620

Reserves (INR Cr)

97149228254555

Net worth (INR Cr)

101154244270575

Total borrowings (INR Cr)

02266407041,398

Other liabilities (INR Cr)

116414755

Goodwill and intangibles (INR Cr)

00000

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Cash from operating activities (INR Cr)

-58-175-359-142-695

Cash from investing activities (INR Cr)

67-85-5790-173

Cash from financing activities (INR Cr)

026948656925

Net cash flow (INR Cr)

9870457

Free cash flow aggregator definition (INR Cr)

-60-175-361-143-699

Dividends paid (INR Cr)

00000

Buybacks (INR Cr)

00000

Margin Analysis (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE reported by Screener (%)

116887

ROE company reported weighted (%)

————8.82

ROA on average total assets (%)

11.23.32.42.11.9

ROA company reported weighted (%)

————2.31

Debt to equity (x)

0.001.472.622.612.43

Interest coverage PBT plus interest over interest (x)

—2.81.51.31.3

Asset turnover revenue over average assets (x)

0.150.140.150.170.14

Capital adequacy CRAR (%)

————32.08

Gross NPA (%)

———2.481.94

Net NPA (%)

———2.111.65

Stage 2 assets (%)

———12.605.90

Cost of borrowings Q4 (%)

————12.17

Income Statement

MetricQ1FY2026Q2FY2026Q3FY2026Q4FY2026Q1FY2027

Revenue (INR Cr)

48515364.6776.86

Finance cost (INR Cr)

2526313841

Operating expenses (INR Cr)

1717121216

Profit before tax (INR Cr)

6891518.82

Net profit (INR Cr)

3.146711.0914.01

AUM (INR Cr)

9441,0281,1561,541.171,599.23

Disbursements (INR Cr)

322360387699.91—

Region revenue (INR Cr)

Region revenue (INR Cr)FY2024FY2025FY2026

India

97.70160.96210.29

Outside India

000

Operating Metrics (number)

MetricFY2024FY2025

States and UTs of presence (number)

1626

Valuation Snapshot

MetricValueSource

Price (19 Oct 2026 close)

₹141

Screener.in

Market cap

~₹2,797 Cr

Screener.in

52-week high / low

₹144 / ₹94.1

Screener.in

1-year return

~43%

Screener (stock price CAGR)

3-year CAGR

~12%

Screener

5-year CAGR

~92%

Screener

Beta

~0.88 (legacy listing data)

Snowball Analytics

Price point (INR)

Date

Source

61.60

28 Jan 2022 (pre-split, ₹2 FV)

Equity Bulls

129.30

3 Nov 2023 (NSE listing approval)

Business Today

69.66

8 May 2025

IIFL

107.50

8 Dec 2025

Kotak Securities

116.65

22 Apr 2026

Kotak Neo

133.86

30 Jun 2026

Bajaj Finserv

143.90

12 Aug 2026 (52-week high)

Whalesbook

141.00

19 Oct 2026

Screener

Valuation Multiples

MultipleMufin Green FinancePeer reference

P/E trailing (x)

73.3

Aye Finance 17.7 (May 2026)

P/B (x)

4.86

Aye Finance 1.35; peer average <1 (May 2026)

Market cap / revenue TTM (x)

11.4—

P/E on FY2027 guidance midpoint ₹85 Cr (x)

32.9

computed; dilution from warrants ignored

EV/EBITDA

Not meaningful for an NBFC

—

Share Price & Returns

DateInstrumentSizePrice

FY2024 (Series B)

Preferential shares / warrants

₹140 Cr

—

Nov 2023 – early 2024

2:1 bonus

——

25 Jan & 8 Feb 2024

Warrant conversions (27.4 lakh and 45.6 lakh shares)

——

Date n/d

Warrant conversion (36.25 lakh warrants)

₹14.95 Cr

~₹41 per share (computed)

4 Mar 2026

Preferential equity + warrants

₹324 Cr

₹98

13 Oct 2026

ESOP allotment

——

Analyst Ratings & Targets

DateAgencyInstrumentRating / outlook

10 Aug 2023

Acuité

₹60 Cr NCD, ₹100 Cr bank lines, bond

BBB / Stable

28 Dec 2023

Acuité

NCDs (₹90 Cr new + ₹60 Cr), bank lines

BBB / Stable

30 May 2024

Acuité

₹150 Cr NCD, ₹250 Cr bank lines, bond

BBB / Positive

6 Jun 2024

Acuité

₹150 Cr NCD, bank lines (₹270 Cr), bond

Upgraded to BBB+ / Stable

7 Apr 2025

Acuité

NCD, bond (₹100 Cr), bank lines

BBB+ / Stable (reaffirmed)

17 Apr 2025

Acuité

Same

Upgraded to A- / Stable (consolidated with Hindon Mercantile)

4 Sep 2025

Acuité

₹100 Cr new NCD (₹200 Cr reaffirmed)

A- / Stable

Mar – Sep 2026

CRISIL

PTCs: MediClaim Trust 2026, Astral Trust 2026

Structured-finance ratings (levels n/d)

Capital Instruments

InstrumentAmountCouponTenor / maturity

DFC loan

US$18M

—

10 years (from Jan 2025)

USD bonds (Global Securities Market)

US$5M

——

NCDs allotted 11 Feb 2026

₹100 Cr

11% (reported)

—

NCDs allotted 15 Jun 2026

₹19 Cr

——

NCDs allotted 21 Jul 2026

₹55 Cr

10%

15 months (Oct 2027)

NCDs Aug 2026

₹50 Cr and ₹75 Cr

——

ECB notes (India INX)

US$6M

——

Wint Wealth NCD facility

₹100 Cr

——

Union Bank of India term loan

₹25 Cr

——

Analyst Conclusions

Management guidance (FY2027)

AUM ~₹2,500 Cr (+62% vs FY2026); PAT ₹80–90 Cr (~3x FY2026); mediclaim at 50–60% of AUM; continued cost-of-funds reduction; headcount toward ~300.

Consensus

None available (no sell-side coverage).

Bull case

  1. Operating leverage is real and visible. Q1 FY2027 revenue grew 60% while opex fell 17%, and PAT rose from ₹3.1 Cr to ₹14.0 Cr YoY. If the digital mix reaches 55–60%, NII flows disproportionately to PAT and ROE could move from ~7% toward the low teens.

  2. Funding cost tailwind compounds. A 263 bps YoY fall in cost of funds to 11.17%, an A- rating, new PSU-bank lines and coupons now at 10% suggest further repricing as older 13–14% debt runs off, especially if a further upgrade follows.

  3. Balance sheet de-risked for growth. CRAR of 32% and net worth of ₹575 Cr can support ₹2,500 Cr+ AUM without fresh equity, and asset quality is improving (Stage 2 down from 12.6% to 5.9%).

Bear case

  1. Credit risk is untested. Mediclaim and Salary Saathi have not been through a full cycle. Low early NPAs in a fast-growing book are partly an arithmetic artefact ("denominator effect"), and losses could surface in FY2028.

  2. Valuation already discounts success. At ~4.9x book and ~73x trailing earnings vs NBFC peers near 1–1.5x book, even hitting the ₹80–90 Cr guidance implies ~33x forward P/E. Any miss on the ~60–80% quarterly PAT step-up needed in Q2–Q4 could de-rate the stock sharply.

  3. Governance and related-party complexity. Promoter-MD control, four material RPTs, intertwined group fintechs, an auditor resignation and a press-release clarification add disclosure risk. Promoter holding fell below 50%.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableTimingWhat to watch
Q2 FY2027 results~early–mid Nov 2026PAT run rate vs ~₹22–25 Cr/quarter needed; AUM vs ₹2,500 Cr path; GNPA
Mediclaim book seasoningQuarterly30+/90+ DPD, insurer concentration, securitisation performance (CRISIL PTC surveillance)
Acuité annual review~Apr–Sep 2027 (Sep 2025 rating valid to 25 Aug 2026; renewal status to confirm)Potential A / Stable upgrade
Promoter warrant conversionWithin 18 months of Mar 2026₹75 Cr inflow (76.5 lakh × ₹98, computed balance due) and promoter stake recovery
Climate book run-offQuarterlyCollections on the shrinking EV book; DFI covenant compliance
Related-party transactionsOngoingFlows with Mufin Pay, LKP/Gyftr, Bimapay, Hindon Mercantile
RegulatoryOngoingRBI digital-lending and consumer-credit norms; IRDAI premium-instalment rules
Q4 FY2027 / FY2027 results~May 2027Delivery vs ₹80–90 Cr PAT guidance

Analyst verdict

APM Finvest has ceased to exist in any meaningful sense except as a legal shell. The listed company is now Mufin Green Finance, a promoter-led, wholesale-funded NBFC in the middle of a second reinvention: from investment holding company to EV lender (2022–2025), and now from EV lender to digital consumer financier (2025 onward). The latest data are strong. Q1 FY2027 PAT more than quadrupled YoY to ₹14 Cr, AUM grew 69% to ₹1,599 Cr, cost of funds fell 263 bps, GNPA is below 2%, and a ₹324 Cr equity raise pushed CRAR to 32%. Few Indian small-cap NBFCs combine that much growth, an improving rating trajectory and visible operating leverage.

Three questions remain open. The first is credit quality: the mediclaim and payroll books that now drive the story are too young to judge, and premium financing depends on a handful of insurer relationships whose terms are not disclosed. The second is scale versus guidance: ₹80–90 Cr PAT for FY2027 requires roughly a 60–80% step-up from the Q1 run rate in the remaining three quarters, while AUM must grow by about ₹100 Cr a month. The third is governance: an auditor resignation, a corrected press release, material related-party transactions and a dense web of group fintech entities call for a higher disclosure standard than the company currently meets.

On valuation, the market already prices in substantial success. At roughly 4.9x book and 33x guided forward earnings (before warrant dilution), the stock carries limited margin of safety against an execution or credit stumble.

Net view: fundamentally improving, but speculative at current prices. Suitable as a monitored position, sized for high volatility, with Q2 and Q3 FY2027 delivery against guidance and the first full-cycle mediclaim delinquency data as the decisive tests. Not institutional-core until coverage, disclosure depth and an independent rating at A or above are established.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenureBackground / educationAgeFY compensation

Kapil Garg

Promoter, Managing Director (Executive Director)

Board since 9 Mar 2022

Co-founder of Mufin Group (2016). Chartered Accountant (India) and CPA (Australia). Directorships include Bimapay Finsure, Mufin Green Leasing, Mufin Green Infra

~44 in Feb 2024 per SEBI DPS (~46–47 now)

Not publicly disclosed in reviewed sources (see AR FY2026 MGT/remuneration annexure)

Gunjan Jain (CA)

Chief Financial Officer

Since 14 Nov 2022

Chartered Accountant

——

Mayank Pratap Singh

Company Secretary & Compliance Officer

At least May 2022 – 2024

Company Secretary

——

Dhiraj Agrawal

Chief Business Officer

————

Darpan Tiwari

President, Partnerships & Alliances

————

Waquar Ali Syed

VP, Collection & Strategy

————

Pankaj Gupta

CEO (named Aug 2022)

Current status not confirmed

———

Rajat Goyal

Co-founder, Mufin Group

Group level

———

Board of Directors

DirectorCategoryAppointedCommittee roles (Apr 2026 governance filing)

Manoj Kumar Bhatt (DIN 09452843)

Chairman, Non-Executive Independent

9 Mar 2022

Audit Committee member; NRC member

Hemant Bhageria (DIN 06476292)

Non-Executive Independent

9 Mar 2022

Audit Committee Chair; NRC member; chair of a third committee (likely Stakeholders Relationship)

Nitin Goel (DIN 01737352)

Non-Executive Independent

9 Mar 2022

NRC Chair; member of another committee

Kapil Garg (DIN 01716987)

Managing Director (Executive)

9 Mar 2022

Audit Committee member

Sanchi Pandey (DIN 08210470)

Independent Director (woman director)

By FY2025

—

Srishti Agarwal (DIN 10229578)

Non-Executive Non-Independent

11 Aug 2023

—

Luv Khanna

Director (per third-party database)

——

Shareholding Trend

Holder category (%)Mar2023Mar2024Mar2025Mar2026Jun2026

Promoters

58.1954.7754.3147.3047.30

FIIs

0.000.111.251.182.26

DIIs

14.1213.1612.539.2910.05

Public

27.6931.9631.9242.2240.39

Number of shareholders

10,52122,13325,97125,76724,964

Major Shareholders

HolderTypeStake

Hindon Mercantile Ltd

Promoter (parent)

Majority of the promoter group's 47.30%; exact split n/d

Kapil Garg

Promoter

16,40,000 shares (0.83%) [Src: Bajaj Finserv shareholding page, 2026]

Pooja Garg

Promoter group

—

SageOne Investments (fund/AIF)

Preferential investor, Mar 2026

—

Sandeep Kapadia

Preferential investor, Mar 2026

—

DS Group

Preferential investor, Mar 2026

—

MMG family office

Preferential investor, Mar 2026

—

Competitive Landscape

Competitors by Segment

VerticalNamed competitorsNotes

EV / climate finance

Revfin, Vidyut, Three Wheels United, OTO Capital, Ecofy, Hero FinCorp, evfin, Finayo, Bajaj Finance and bank captives (2W EV)

Revfin raised a US$14M Series B (Omidyar) in early 2024; most specialists are unlisted [Src: Entrackr, Mar 2024]

Insurance-premium / health EMI finance

Bajaj Finance (EMI network), insurer-partnered BNPL/fintech NBFCs, credit-card EMI by banks

No listed pure-play peer identified

Payroll / salary-linked loans

Kinara/Fibe-type salaried lenders, PSU banks' personal loans, NBFC personal-loan apps

—

MSME secured loans

UGRO Capital, Aye Finance, Arman Financial, Moneyboxx, Paisalo Digital

Listed small/mid-cap NBFCs

Listed small NBFC comparables

Apollo Finvest (NBFC-as-a-service), Aye Finance, UGRO Capital, Paisalo Digital

Used for valuation context

Peer Comparison FY2026

MetricMufin Green FinanceApollo FinvestAye Finance

Revenue FY2026 (INR Cr)

210.2920.7—

PAT FY2026 (INR Cr)

28.216.96—

P/E May 2026 (x)

106.13—17.67

P/B May 2026 (x)

6.63—1.35

Company Snapshot

$24.3M

Revenue

537

Employees

2016

Founded

District Alwar, India

Headquarters

SWOT Analysis

Strengths

  • Rapid profitable scaling: AUM up 83.8% in FY2026 to ₹1,541 Cr and up 69.4% YoY to ₹1,599 Cr in Q1 FY2027; PAT up 346% YoY in Q1 FY2027 [Q4 FY26 / Q1 FY27 updates].
  • Improving asset quality: GNPA fell from 2.48% to 1.94% and NNPA from 2.11% to 1.65% in FY2026; Stage 2 fell from 12.6% to 5.9% [FY26 release].
  • Strong capitalisation: CRAR 32.08% after the ₹324 Cr raise; net worth ₹575 Cr at FY2026 [ScanX; Screener].
  • Falling cost of funds: Down 263 bps YoY to 11.17% (Q1 FY2027) [ScanX].
  • Rating trajectory: Upgraded three notches since 2023, from BBB to A- (Stable) [Acuité RRs 2023–2025].
  • Operating leverage: Q1 FY2027 opex down 17.2% YoY while revenue rose 60% [SolarQuarter, Aug 2026].
  • Diversified funding: Banks, IREDA, DFC, BlueOrchard, NCD platforms, securitisation and India INX notes [multiple].

Weaknesses

  • Low historical ROE: ~7% in FY2026 and 3-year average ~7.4% (Screener) — below cost of equity.
  • Thin interest coverage: (PBT + interest) / interest ~1.3x in FY2025–FY2026 (computed).
  • Heavy negative operating cash flow: −₹695 Cr in FY2026 means constant reliance on external funding [Screener].
  • No dividend since takeover; earnings fully retained.
  • Disclosure gaps and errors: Assam press-release clarification (Mar 2026); inconsistent PAT-growth framing ("tripled" vs +39%); vertical data not restated.
  • Auditor resignation mid-term (Tattvam & Co., Aug 2025).

Opportunities

  • Mediclaim scaling to 50–60% of AUM in a large, under-penetrated health-insurance market [Q4 FY26 call].
  • FY2027 guidance: ₹80–90 Cr PAT would roughly triple FY2026 profit [ScanX].
  • Securitisation of digital pools (MediClaim Trust) can recycle capital and lower funding costs [CRISIL ratings].
  • Green bond / ECB / DFI capital for the climate book at concessional cost [India INX listing Sep 2026].
  • Government payroll channels beyond Assam for Salary Saathi.
  • Further rating upgrade to A/A+ if profitability scales, which would open bank and MF funding at lower spreads.

Threats

  • Concentration risk: Dependence on a handful of insurer partners for 42% of AUM.
  • Regulatory risk: RBI digital-lending, outsourcing and consumer-credit rules; IRDAI changes to premium instalment rules.
  • EV credit cycle: E-rickshaw over-capacity and battery-tech obsolescence could hurt the run-off climate book.
  • Related-party risk: Four material RPTs approved at the 2026 AGM; intertwined group entities (Mufin Pay, LKP/Gyftr, Bimapay).
  • Valuation de-rating: Shares at ~4.9x book and ~73x trailing P/E vs peers below 1.5x book.
  • Funding shock: A sector-wide liquidity tightening (as ICRA flagged for FY2025) hurts mid-rated NBFCs first.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
7 Apr 2025Acuité reaffirms BBB+ (Stable) on bank lines, bonds and ₹150 Cr NCDs Acuité RR 7 Apr 2025Baseline before upgrade
17 Apr 2025Acuité upgrades to A- (Stable); rating now assessed on consolidated Hindon Mercantile + MGFL Acuité RR 17 Apr 2025Key driver of lower funding cost
Apr 2025Group completes majority stake in LKP Finance Outlook BusinessGroup capital and related-party complexity
May 2025FY2025 results: revenue ₹161 Cr (standalone), PAT ~₹20.3 Cr; AUM ₹838 Cr; GNPA 2.48% ICICI Direct; FY26 comparativesPre-pivot base year
11 & 18 Jul 2025Allotments of securities (NCDs) CMOTS announcementsOngoing debt raising
Aug 2025Q1 FY2026: PAT ₹3.14 Cr; cost of funds 13.80% Q1 FY27 comparativesTrough quarter
28 Aug 2025Board approves ₹50 Cr NCD; auditor change (Tattvam & Co. resigns; Gaur & Associates appointed) Board outcomeGovernance flag
4 Sep 2025Acuité assigns A- (Stable) to proposed ₹100 Cr NCDs FilingReaderFunding capacity
29 Sep 20259th AGM Board outcome—
6 Nov 2025Board approves preferential issue; Q2 FY2026 results (consolidated PAT +26%) ScanX; CholaEquity raise launched
7–29 Nov 2025EGM notice, corrigendum modifying the allotment, EGM approval ScanXCapital raise
Jan 2026Q3 FY2026: AUM ₹1,156 Cr; EPS ₹0.41 Kotak Neo; Q4 callMomentum building
28 Jan 2026₹41.45 Cr preferential tranche withdrawn due to regulatory delays ScanXExecution hiccup
29 Jan 2026Board approves NCDs of up to ₹125 Cr ScanXFunding
11 Feb 2026₹100 Cr NCDs allotted (11% coupon reported) ScanXFunding at lower cost
~18 Feb 2026In-principle NSE/BSE approval for preferential issue ScanXCapital raise
1–3 Mar 2026Assam government empanelment press release, then regulatory clarification IndiaIPODisclosure-quality flag; Salary Saathi channel
4 Mar 2026₹324 Cr preferential allotment completed (₹98/share) Allotment filingNet worth more than doubles
Mar 2026CRISIL rates PTCs of MediClaim Trust 2026 Screener rating linksSecuritisation of mediclaim pool
Q4 FY2026Promoter stake falls to 47.30% from 54.11% MarketsMojoDilution; warrants pending
21–25 May 2026FY2026 results: AUM ₹1,541 Cr (+83.8%), PAT ₹28.21 Cr, GNPA 1.94%, NNPA 1.65%; FY2027 guidance ₹80–90 Cr PAT and ₹2,500 Cr AUM Press release; presentationGuidance reset upward
4 Jun 2026Q4 FY2026 earnings call; mediclaim targeted at 50–60% of AUM TranscriptStrategy confirmation
15 Jun 2026₹19 Cr NCDs allotted ScanXFunding
14 Jul 2026Board approves NCDs up to ₹75 Cr and US$6M ECB bonds SahiOffshore funding
21 Jul 2026₹55 Cr secured listed NCDs allotted (10% coupon, 15-month tenor, Oct 2027 maturity) SolarQuarterLowest disclosed coupon to date
Jul 2026CRISIL rates PTCs of Astral Trust 2026 (updated 28 Sep 2026) Screener rating linksAdditional securitisation
11 Aug 2026Q1 FY2027: revenue ₹76.86 Cr (+60%), PAT ₹14.01 Cr (+346%), AUM ₹1,599 Cr (+69%), GNPA 1.91%, cost of funds 11.17% Whalesbook; ScanXProfit inflection
12 Aug 2026Stock hits 52-week high of ₹143.90 WhalesbookMarket validation
Aug 2026₹50 Cr and ₹75 Cr listed debentures allotted InCred Money news feedFunding
20 Aug 2026Virtual analyst meet ScanXIR engagement
5 Sep 2026FY2026 Annual Report dispatched; CRAR 32.08% disclosed ScanXCapital strength
22 Sep 2026US$6M notes listed on India INX ScanXOffshore funding executed
28 Sep 202610th AGM; six resolutions passed, including four material RPTs BSERelated-party scrutiny
29 Sep 2026Trading window closed from 1 Oct pending Q2 FY2027 results BSEResults due ~early/mid Nov 2026
13 Oct 2026Shares allotted on ESOP exercise BSEMinor dilution

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Revenue by Segment (FY2025–2027): Total AUM rose from INR 8,384.4 Mn in FY2025 to INR 15,992.3 Mn in 2027.
Mufin Green Finance Limited — Revenue by Segment (FY2025–2027)
Series (INR Mn)FY2025FY20262027
Total AUM8,384.415,411.715,992.3
Mediclaim Financing—6,078.86,766.1
Climate Financing EV and Solar—4,623.54,108.3
Other Loans MSME and Corporate—4,469.44,588.4
Salary Saathi—308.2529.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. BSE corporate filings, APM Finvest Ltd (2020–2022): large-corporate disclosures, Form C, board-meeting notices, results (bseindia.com, scrip 542774)
  2. NSE listing letter NSE/LIST/136 (2 Nov 2023) and circular NSE/CML/59232 (3 Nov 2023)
  3. Mufin Green Finance: FY2024 audited results and notes (NSE, 28 May 2024) · Q1 FY2025 results (NSE, 13 Aug 2024) · BRSR FY2023-24 (BSE)
  4. Mufin Green Finance: Q4 & FY2025-26 investor presentation (BSE/NSE, 25 May 2026) · Q4 FY2026 earnings-call transcript (BSE, 4 Jun 2026) · Q1 FY2027 investor update (BSE, Aug 2026) · FY2026 Annual Report cover letter (NSE, 5 Sep 2026) · NSE integrated governance filing (25 Apr 2026)
  5. Acuité Ratings & Research rationales: 10 Aug 2023, 28 Dec 2023, 30 May 2024, 6 Jun 2024, 7 Apr 2025, 17 Apr 2025, 4 Sep 2025
  6. SEBI: LKP Finance Draft Letter of Offer and Detailed Public Statement (Feb 2024) · BSE outcome 3 Feb 2024
  7. Screener.in (C-MOTS data): standalone P&L, balance sheet, cash flow, ratios, shareholding, documents (accessed 19 Oct 2026)
  8. ICICI Direct rapid results (Q4 FY26): MarketsMojo (Q4 FY26 analysis, 22 May 2026) · ScanX news feed (2025–2026) · Multibagg summaries (FY26, Q1 FY27) · Whalesbook, Univest, Sahi (Q1 FY27) · SolarQuarter (Jul–Aug 2026) · Agro Spectrum (26 May 2026)
  9. Energetica India, Goodreturns, TipRanks, IndiaIPO (Mar 2026 preferential issue): LinkedIn company update
  10. Arihant Capital / CMOTS company profile, name-change and board tables: Motilal Oswal MarketsMojo company CV
  11. Outlook Business, Entrackr, Entrepreneur India, YourStory, EVreporter, EMobility+ (2022–2025 funding and LKP coverage): Business Today and DSIJ (NSE listing, Nov 2023; subsidiary, Mar 2024)
  12. Outlook Business / Entrepreneur India (Jan 2026, LKP–Gyftr): Tracxn · CB Insights · Dealroom · Inc42
  13. ICRA NBFC-Retail sector outlooks (Apr 2024, Jul 2024)
  14. FinancialFilings (Apollo Finvest FY2026): Simply Wall St · Morningstar · Musaffa · Snowball Analytics · Kotak Securities/Kotak Neo · Bajaj Finserv · IIFL · Equity Bulls

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.